SUSAN LEPPKE

Policies related to laboratory developed tests.

Supporting policies intended strengthen the blood supply.

Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care.

-Advancing policies that support the blood supply. -Cures 2.0 discussion draft and Advanced Research Projects Agency for Health (ARPA-H) request for information.

Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care. Supporting a bill that would authorize the Centers for Medicare and Medicaid Services (CMS) to develop a program for Medicaid beneficiaries to improve access to comprehensive outpatient care for individuals with sickle cell disease.

Advancing policies that support the blood supply.

Support for innovative payment models for novel biotherapies.

Appropriations for the Center for Biologics Evaluation and Research at the Food and Drug Administration in the FY 2022 appropriations bill for the Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. Appropriations for implementation of section 3226 of the Coronavirus Aid, Relief, and Economic Security Act (P.L. 116-136)

Advancing policies that support the blood supply.

Appropriations for National Institutes of Health and the Centers for Disease Control and Prevention in the FY 2022 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.

Support for (1) research and activities related to blood donor awareness and engagement; (2) a data infrastructure that capture real-time data on the blood supply; and (3) a public-private partnership to advance policy solutions for the U.S. blood system.